NeOnc Technologies Holdings, Inc. (NTHI)
Nasdaq: NTHI · Pharmaceutical Preparations · Calabasas, CA · filing with the SEC since 2023
Who owns NeOnc Technologies Holdings, Inc.
As filed with the SECHolders of 5% or more
2
Amir F. Heshmatpour holds 34.3% of COMMON STOCK, par value $0.0001 per share, as its SCHEDULE 13D filed Apr 25, 2025 says.
Directors and officers
8
report now, of 13 people on the record since 2025. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Amir F. Heshmatpour
SCHEDULE 13D · filed Apr 25, 2025 · COMMON STOCK, par value $0.0001 per share
Cinctive Capital Management LP
SCHEDULE 13G · filed May 15, 2026 · Common Stock, par value $0.0001 per share
What NTHI reports owning in othersstakes of 5% or more, and other ties
NeOnc Technologies Holdings, Inc. reports no stake in another company in the record.
Insider tradesForm 4
1sales
38purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$2.1Mbought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 15 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Heshmatpour Amir F | CEO, President | 0 | $0 | 0 | 23 | $1.6M |
| Chen Thomas C | CMO | 0 | $0 | 0 | 11 | $500,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer | 0 | $0 | 0 | 2 | $0 |
| Garnett Keithly | CFO | 1 | $0 | 0 | 1 | $0 |
| Suh, David Jr. | Chief Accounting Officer | 0 | $0 | 0 | 1 | $0 |